Heparanase and cancer progression: New directions, new promises

References

• Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68:729-77; PMID:10872465; http://dx.doi.org/10.1146/annurev.biochem.68.1.729
   PubMed Web of Science ®Google Scholar
• Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem & Cell Biol 2006; 38:2018-39; http://dx.doi.org/10.1016/j.biocel.2006.06.004
   PubMed Web of Science ®Google Scholar
• Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001; 1471:M99-108; PMID:11250066
   PubMed Web of Science ®Google Scholar
• Vlodavsky I, Beckhove P, Lerner I, Pisano C, Meirovitz A, Ilan N, Elkin M. Significance of heparanase in cancer and inflammation. Cancer Microenviron 2012; 5:115-32; PMID:21811836; http://dx.doi.org/10.1007/s12307-011-0082-7
   PubMedGoogle Scholar
• Abboud-Jarrous G, Atzmon R, Peretz T, Palermo C, Gadea BB, Joyce JA, Vlodavsky I. Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment. J Biol Chem 2008; 283:18167-76; PMID:18450756; http://dx.doi.org/10.1074/jbc.M801327200
   PubMed Web of Science ®Google Scholar
• Vlodavsky I, Ilan N, Naggi A, Casu B. Heparanase: Structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 2007; 13:2057-73; PMID:17627539; http://dx.doi.org/10.2174/138161207781039742
   PubMed Web of Science ®Google Scholar
• Vreys V, David G. Mammalian heparanase: what is the message? J Cell & Mol Med 2007; 11:427-52; http://dx.doi.org/10.1111/j.1582-4934.2007.00039.x
   PubMed Web of Science ®Google Scholar
• Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 2004; 96:1219-30; PMID:15316057; http://dx.doi.org/10.1093/jnci/djh230
   PubMed Web of Science ®Google Scholar
• Thompson CA, Purushothaman A, Ramani VC, Vlodavsky I, Sanderson RD. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem 2013; 288:10093-9; PMID:23430739; http://dx.doi.org/10.1074/jbc.C112.444562
   PubMed Web of Science ®Google Scholar
• Goodall KJ, Poon IK, Phipps S, Hulett MD. Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4. PloS One 2014; 9:e109596.
   PubMed Web of Science ®Google Scholar
• Hermano E, Meirovitz A, Meir K, Nussbaum G, Appelbaum L, Peretz T, Elkin M. Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme. J Natl Cancer Inst 2014; 106 (12); PMID:25326645; http://dx.doi.org/10.1093/jnci/dju332
   PubMedGoogle Scholar
• Shteingauz A, Boyango I, Naroditsky I, Hammond E, Gruber M, Doweck I, Ilan N, Vlodavsky I. Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy. Cancer Res 2015; 75:3946-57; PMID:26249176; http://dx.doi.org/10.1158/0008-5472.CAN-15-0037
   PubMed Web of Science ®Google Scholar
• Ramani VC, Zhan F, He J, Barbieri P, Noseda A, Tricot G, Sanderson RD. Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma. Oncotarget 2015; 7:1598-607
   Web of Science ®Google Scholar
• Hammond E, Khurana A, Shridhar V, Dredge K. The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumor microenvironment and opportunities for novel cancer therapeutics. Front Oncol 2014; 4:195; PMID:25105093; http://dx.doi.org/10.3389/fonc.2014.00195
   PubMedGoogle Scholar
• Barash U, Cohen-Kaplan V, Dowek I, Sanderson RD, Ilan N, Vlodavsky I. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. The FEBS J 2010; 277:3890-903; PMID:20840586; http://dx.doi.org/10.1111/j.1742-4658.2010.07799.x
   PubMed Web of Science ®Google Scholar
• Fux L, Ilan N, Sanderson RD, Vlodavsky I. Heparanase: busy at the cell surface. Trends Biochem Sci 2009; 34:511-9; PMID:19733083; http://dx.doi.org/10.1016/j.tibs.2009.06.005
   PubMed Web of Science ®Google Scholar
• Sanderson RD, Iozzo RV. Targeting heparanase for cancer therapy at the tumor-matrix interface. Matrix Biol 2012; 31:283-4; PMID:22655968; http://dx.doi.org/10.1016/j.matbio.2012.05.001
   PubMed Web of Science ®Google Scholar
• Levy-Adam F, Abboud-Jarrous G, Guerrini M, Beccati D, Vlodavsky I, Ilan N. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase. J Biol Chem 2005; 280:20457-66; PMID:15760902; http://dx.doi.org/10.1074/jbc.M414546200
   PubMed Web of Science ®Google Scholar
• Weissmann M, Arvatz G, Horowitz N, Feld S, Naroditsky I, Zhang Y, Ng M, Hammond E, Nevo E, Vlodavsky I, et al. Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis. Proc Nat Acad Sci USA 2016; 113:704-9; PMID:26729870; http://dx.doi.org/10.1073/pnas.1519453113
   PubMed Web of Science ®Google Scholar
• Ebos JM. Prodding the Beast: Assessing the impact of treatment-induced metastasis. Cancer Res 2015; 75:3472-35; http://dx.doi.org/10.1158/0008-5472.CAN-15-0308
   Web of Science ®Google Scholar
• Goldberg R, Meirovitz A, Hirshoren N, Bulvik R, Binder A, Rubinstein AM, Elkin M. Versatile role of heparanase in inflammation. Matrix Biol 2013; 32:234-40; PMID:23499528; http://dx.doi.org/10.1016/j.matbio.2013.02.008
   PubMed Web of Science ®Google Scholar
• Hagerling C, Casbon AJ, Werb Z. Balancing the innate immune system in tumor development. Trends Cell Biol 2015; 25:214-20; PMID:25444276; http://dx.doi.org/10.1016/j.tcb.2014.11.001
   PubMed Web of Science ®Google Scholar
• Dai H, Wang Y, Lu X, Han W. Chimeric antigen receptors modified T-Cells for cancer therapy. J Natl Cancer Inst 2016; 108 (7); PMID:26819347
   PubMedGoogle Scholar
• Sommerfeldt N, Beckhove P, Ge Y, Schutz F, Choi C, Bucur M, Domschke C, Sohn C, Schneeweis A, Rom J, et al. Heparanase: a new metastasis-associated antigen recognized in breast cancer patients by spontaneously induced memory T lymphocytes. Cancer Res 2006; 66:7716-23; PMID:16885374; http://dx.doi.org/10.1158/0008-5472.CAN-05-2363
   PubMed Web of Science ®Google Scholar
• Zhang YF, Tang XD, Gao JH, Fang DC, Yang SM. Heparanase: a universal immunotherapeutic target in human cancers. Drug Discov Today 2011; 16:412-7; PMID:21376137; http://dx.doi.org/10.1016/j.drudis.2011.02.015
   PubMed Web of Science ®Google Scholar
• Bonertz A, Weitz J, Pietsch DH, Rahbari NN, Schlude C, Ge Y, Juenger S, Vlodavsky I, Khazaie K, Jaeger D, et al. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J Clin Invest 2009; 119:3311-21; PMID:19809157
   PubMed Web of Science ®Google Scholar
• Chen T, Tang XD, Wan Y, Chen L, Yu ST, Xiong Z, Fang DC, Liang GP, Yang SM. HLA-A2-restricted cytotoxic T lymphocyte epitopes from human heparanase as novel targets for broad-spectrum tumor immunotherapy. Neoplasia 2008; 10:977-86; PMID:18714399; http://dx.doi.org/10.1593/neo.08576
   PubMed Web of Science ®Google Scholar
• Zhou K, Zhu H, Huang L, Guo Y, Yan Y. Induction of anti-tumor immunity by dendritic cells pulsed with an endoplasmic reticulum retrieval signal modifies heparanase epitope in mice. Cytotherapy 2010; 12:735-42; PMID:20230227; http://dx.doi.org/10.3109/14653241003615156
   PubMed Web of Science ®Google Scholar
• Caruana I, Savoldo B, Hoyos V, Weber G, Liu H, Kim ES, Ittmann MM, Marchetti D, Dotti G. Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes. Nature medicine 2015; 21:524-9; PMID:25849134; http://dx.doi.org/10.1038/nm.3833
   PubMed Web of Science ®Google Scholar
• Wu L, Viola CM, Brzozowski AM, Davies GJ. Structural characterization of human heparanase reveals insights into substrate recognition. Nat Struct Mol Biol 2015; 22:1016-22; PMID:26575439; http://dx.doi.org/10.1038/nsmb.3136
   PubMed Web of Science ®Google Scholar